Clinical Notes: Rat Data Suggest Eye Risk for CF Drug

(MedPage Today) — Cataracts developed in young rats treated with the cystic fibrosis drug ivacaftor (Kalydeco), prompting the FDA to order a label change. Also this week: a fatal viral infection stalks Yosemite Park.

Post a Comment

Comments are closed.